New Ads Are Running on Digital Platforms in AZ, NJ & WV

Watch “Arizona Patients Can’t Wait” Here

Watch “New Jersey Patients Can’t Wait” Here

Watch “West Virginia Patients Can’t Wait” Here

Washington, DC — Protect Our Care launched new digital ads in Arizona, New Jersey, and West Virginia as part of a multi-million dollar campaign about the skyrocketing cost of prescription drugs. The ads showcase the impact on patients when drug companies hike the price of essential medicines again and again. The ads make clear the importance of giving Medicare the power to negotiate with drug companies for lower prices for all Americans.

The ads are part of The Campaign to Reduce Drug Prices, a grassroots and communications campaign calling for comprehensive legislation to lower drug prices. This ad series is running on digital platforms, focusing particularly on older residents. Protect Our Care will continue to run ads and host events both nationally and in 14 key states, including Arizona, New Jersey, and West Virginia, throughout the summer.

“It is shameful that Americans pay three times more for medicines than people in other countries,” said Protect Our Care Executive Director Brad Woodhouse. “While drug company profits soar, they continue to hike the price of lifesaving drugs for people across the country, forcing millions of families to choose between paying for the medicines they need to live or paying for food or rent. It’s time for lawmakers to do the right thing and support giving Medicare the power to negotiate for lower drug prices. The time to act is now.”

Example Script (AZ): “Arizona Patients Can’t Wait” (:30s):

It’s always the same thing. 

The costs of prescription drugs keep going up. 

How are patients supposed to afford this?

Families need these life-saving drugs just to stay alive.

Arizona families pay 3 times more than people do in other countries to get the same medicines. 

Drug companies make more and more profits, and drug prices go up and up for patients. 

We can’t wait any longer to act.

Congress needs to give Medicare the power to negotiate lower drug prices